ATOS

Conviction 27HealthcareScan · Thu, Jun 25, 2026

Dragonfly doji

ATOS$1.76+0.29%

ResistanceSupportVol 14

Vol MA14 386.96K

Mar 26Apr 14May 1May 19Jun 8Jun 25

ATOSSA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.atossatherapeutics.com ↗

Price1.76

Change+0.29%

Gap+0.57%

Rel volume0.59×

Avg volume287.01K

Avg $ vol702.03K

SMA 203.43

SMA 504.62

SMA 2002.77

Price vs 50-61.99%

Price vs 200-36.62%

MA stackmixed

50/200 cross—

Supertrenddown · 2.57

RSI (14)16

MACD hist-0.15

MACD cross—

Stoch %K / %D1 / 2

ADX (14)47

+DI / −DI6 / 46

RSI divergence—

MACD divergence—

ATR %+16.72%

ADR %7.20%

52w high6.17

52w low0.5650

From 52w high-71.56%

Above 52w low+210.62%

New 52w highNo

SqueezeOff

Bollinger width160.65%

%B0.20

Donchian pos0.98%

Donchian high5.30

Donchian low1.72

AVWAP (52w high)4.01

vs AVWAP high-56.28%

AVWAP (52w low)3.42

vs AVWAP low-48.69%

OBV trendDown

Chaikin MF (20)-0.47

Today vs 20d0.59×

Avg vol (14d)386.95K

Avg vol (20d)287.01K

Avg $ vol (20d)702.03K

Market cap15.11M

RS 3m (vs SPY)-80.50%

RS 6m (vs SPY)+131.63%

RS line new highNo

Trend template4/8

Technical rank32.6

1 week-11.59%

1 month-64.55%

3 months-67.62%

6 months+144.70%

1 year+112.47%

YTD+178.31%

P/E-0.43

P/B0.50

P/S—

P/FCF-0.51

EPS-4.04

Div yield—

ROE-114.05%

ROA-91.64%

Debt/Eq—

Current4.92

EV/EBITDA0.45

Gross margin—

Net margin—

Rev growth0.00%

EPS growth-36.33%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-16.61M

Revenue0

Net income-9.59M

Gross profit0

Free cash flow-29.79M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees14

ListedThu, Nov 8, 2012

Free float7.68M

Float %89.2%

Short interest401K

Days to cover9.6d

Short volume67.8%

Squeeze score54 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.11 vs −$1.22

Last surprise+9.0% beat

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank32.6 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmDragonfly doji

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ATOS

All disclosures →

No recent disclosed trades by Congress in ATOS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ATOS · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Chen Shu-Chih Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Steinhart Richard I Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Chen Shu-Chih Director · Common Stock · 2026-05-12	Other	—	—	2026-05-12	2026-05-14
Remmel H. Lawrence Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Galli Stephen J Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Finn Jonathan Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14
Cigler Tessa Director · Common Stock · 2026-05-12	Grant	10K	$0	2026-05-12	2026-05-14

SEC filings

EDGAR filings in ATOS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.